Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
SNPS heads into Q2 earnings results with AI-driven chip demand and Synopsys.ai adoption expected to support revenue growth.
Synopsys has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Five-year partnership aims to support next-generation semiconductor research.
Broadcom and Meta Trigger $125 Million AI Chip Race
Synopsys (SNPS) closed the most recent trading day at $503.98, moving +1.01% from the previous trading session.
Evaluate the expected performance of Synopsys (SNPS) for the quarter ended April 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
The average brokerage recommendation (ABR) for Synopsys (SNPS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Synopsys (SNPS) is back in focus after its Q1 FY26 report highlighted 65.4% year-over-year revenue growth and higher non-GAAP EPS, with the Ansys acquisition expanding its addressable market and shaping updated revenue guidance. See our latest analysis for Synopsys. The strong Q1 FY26 update comes after a mixed run for shareholders, with the share price up 10.87% over the past month and 18.13% over 90 days. However, the 1 year total shareholder return is down 3.41%, while the 5 year total...
Shares of Arm Holdings (NASDAQ:ARM) are trading higher by 4% in midday action Tuesday, extending a year that has put the chip-IP designer in a class of its own among semiconductor design names. ARM stock is up 102% year to date (YTD) through Monday, thereby doubling in under five months. The rest of the chip-IP ... Arm Holdings Has Doubled in 2026. Is It Outperforming Other Chip-IP Stocks Like Synopsys, Cadence, and Qualcomm?
Synopsys (NASDAQ:SNPS) has whipsawed investors over the past year, from an August 2025 peak near $617.91 to a November low of $389.83, before settling at $498.43. With the Ansys integration now fully reflected in results and AI-driven chip design demand intact, our model sees room to run. Our 24/7 Wall St. price target for Synopsys ... Prediction: Synopsys Could Hit $600+ in 12 Months and Here’s Why
PRGS vs. SNPS: Which Stock Is the Better Value Option?
Synopsys (NASDAQ:SNPS) below $500 looks priced for an AI story the business does not fully support. The AI multiple attached to this stock fits worse than the valuation implies, and cleaner AI exposure exists elsewhere in the semi stack. Synopsys is the larger of the two electronic design automation giants. It sells the software chip ... Buy, Sell or Hold Synopsis Below $500?
Artificial intelligence is no longer just about who builds the fastest chips. Increasingly, it’s about who controls the infrastructure powering the AI boom — the cloud providers, networking gear, software tools, and data centers that keep those chips humming around the clock. That’s where Nvidia (NASDAQ:NVDA) has been playing a quieter game investors may be ... Nvidia’s Hidden Portfolio Just Doubled Down on CoreWeave Stock
Synopsys (SNPS) concluded the recent trading session at $501.52, signifying a -1.67% move from its prior day's close.
Synopsys (NASDAQ:SNPS) has staged one of the more dramatic comebacks in semiconductor software, climbing 21.78% in the past month after a brutal stretch through late 2025. With the Ansys integration now showing up in the numbers and AI-driven chip design demand intact, our model points to further upside. Our 24/7 Wall St. price target for ... Synopsys Price Prediction: The AI Play With Big Upside This Year
Investing.com -- President Donald Trump's latest OGE Form 278-T disclosure reveals a significant paring of his larger technology securities during the first quarter of 2026. Large-scale sales of securities in Amazon.com Inc (NASDAQ:AMZN), Meta Platforms Inc (NASDAQ:META), and Microsoft Corporation (NASDAQ:MSFT) were recorded in the peak-valuation tier of $5 million to $25 million.
Investing.com -- President Donald Trump’s latest OGE Form 278-T disclosure reveals a significant paring of his larger technology holdings during the first quarter of 2026. Large-scale sales of Amazon.com Inc (NASDAQ:AMZN), Meta Platforms Inc (NASDAQ:META), and Microsoft Corporation (NASDAQ:MSFT) were recorded in the peak-valuation tier of $5 million to $25 million.
The Synopsys fair value estimate is now set at US$534.65, compared with the previous US$533.52, reflecting only a marginal update to the model. Behind that small shift is a mixed analyst backdrop, with some focusing on earlier than expected Ansys related cost synergies and higher EPS guidance. Others flag decelerating electronic design automation growth, reset price targets down to US$480, US$455, and US$430, and softer IP trends. As you read on, you will see how these differing views shape...
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Atomera (NASDAQ:ATOM) executives said the company made progress across several customer engagements during its first-quarter 2026 earnings call, highlighting momentum in advanced logic, memory, RF, power devices, and gallium nitride (GaN) applications for its Mears Silicon Technology (MST). Gate-Al
Moby summary of GLOBALFOUNDRIES Inc.'s Q1 2026 earnings call
In the latest trading session, Synopsys (SNPS) closed at $497.5, marking a +1.73% move from the previous day.
Why Synopsys (SNPS) is on investors’ radar today Synopsys (SNPS) stock has been drawing attention after recent share price moves, with a return of 23.5% over the past month and 16.7% over the past 3 months. See our latest analysis for Synopsys. At around $489 per share, the stock has recently seen a 23.5% 1 month share price return and a 16.7% 3 month share price return. The 1 year total shareholder return of 2.43% and 5 year total shareholder return of 110.43% frame this latest move within a...
Based on the average brokerage recommendation (ABR), Synopsys (SNPS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PRGS vs. SNPS: Which Stock Is the Better Value Option?
Microsoft (MSFT) delivered earnings and revenue surprises of +4.97% and +1.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
I’m leading with the headline because the math here is too important to bury. Synopsys (NASDAQ:SNPS) trades at $483.89, and our 24/7 Wall St. price target points to $597.11 over the next 12 months. That implies 23.4% upside, and the model carries 90% confidence. The setup looks constructive from here. Metric Value Current Price $483.89 ... Synopsys Set Price Surge: Here Is The Bullish Prediction